Key result
Hyaluronate degradation using Streptomyces hyaluronidase significantly increased ventricular performance parameters immediately after cardiac looping and prevented endocardial cushion formation.
Why the study?
Does hyaluronate degradation alter ventricular performance in early postlooped embryonic rat hearts?
Does hyaluronate degradation alter ventricular performance in early postlooped embryonic rat hearts?
Hyaluronate degradation in early embryonic rat hearts alters ventricular performance and prevents normal endocardial cushion formation.
Answers are grounded in this paper and cite their sources.
Hyaluronan degradation may boost early ventricular performance while blocking cushion formation in rat embryos; leaves open any role in human cardiogenesis.
Hyaluronic acid is the major glycosaminoglycan of the early cardiac extracellular matrix or "cardiac jelly," yet little is known about its role in the ontogeny of early ventricular performance. To investigate the in situ effect of hyaluronate degradation on ventricular function, whole rat embryos were cultured in rat serum alone (control embryos) or rat serum plus 20 TRU/mL of Streptomyces hyaluronidase (treatment embryos) from gestational day 9.5 (before formation of the heart tube) through initial looping of the heart. Cardiac function was measured before looping (24 hours in culture) and immediately after looping (36 hours in culture) by video motion analysis of the external wall motion of the bulbus cordis and primitive ventricle. Degradation of hyaluronic acid in the treated embryos was confirmed by Alcian blue staining at pH 2.5. Significant increases in heart rate, circumferential shortening fraction, maximum velocity of circumferential contraction, and maximum velocity of circumferential relaxation were observed with looping in both control and treatment embryos. Although there was minimal difference in ventricular performance between control and treatment embryos before looping, there was a significant increase in all parameters of ventricular performance in the hyaluronidase-treated embryos immediately after looping of the heart. Endocardial cushions were absent in hyaluronidase-treated embryos, and an additional group of embryos cultured in the presence of Streptomyces hyaluronidase for 48 to 72 hours failed to develop endocardial cushions. These experiments are the first to (1) document a quantifiable increase in ventricular performance during early cardiac looping and (2) demonstrate that hyaluronate degradation results in abnormal endocardial cushion formation and altered ventricular performance of the postlooped heart.(ABSTRACT TRUNCATED AT 250 WORDS)
No takes yet. Share an insight, caveat, or question.
Baldwin et al. (1994) studied Early cardiac looping. Streptomyces hyaluronidase vs. Rat serum alone was evaluated on Ventricular performance (heart rate, circumferential shortening fraction, maximum velocity of contraction and relaxation). Hyaluronate degradation using Streptomyces hyaluronidase significantly increased ventricular performance parameters immediately after cardiac looping and prevented endocardial cushion formation.
Synapse has enriched 10 related papers. Consider them for comparative context: